Proteostasis Therapeutics Inc.'s board elected Marija Zecevic, the company's current chief business officer, as COO.
Zecevic has been serving as chief business officer since March 2017.
Proteostasis Therapeutics names COO
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Proteostasis Therapeutics Inc.'s board elected Marija Zecevic, the company's current chief business officer, as COO.
Zecevic has been serving as chief business officer since March 2017.